Form 8-K - Current report:
SEC Accession No. 0001104659-19-055975
Filing Date
2019-10-24
Accepted
2019-10-24 07:00:42
Documents
15
Period of Report
2019-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1920888-1_8k.htm   iXBRL 8-K 24014
2 EXHIBIT 99.1 tm19208881_ex99-1.htm EX-99.1 21272
3 EXHIBIT 99.2 tm19208881_ex99-2.htm EX-99.2 20303
7 GRAPHIC tm19208881_ex99-2img01.jpg GRAPHIC 272441
  Complete submission text file 0001104659-19-055975.txt   628252

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fold-20191024.xsd EX-101.SCH 3216
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20191024_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20191024_pre.xml EX-101.PRE 22730
8 EXTRACTED XBRL INSTANCE DOCUMENT tm1920888-1_8k_htm.xml XML 3483
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 191164788
SIC: 2834 Pharmaceutical Preparations